Pharmacy and drugs - search results: formoterol


	About us	News	A-Z Drugs	Stores	Top Drugs	Contact

Diseases

.: Addiction
.: ADHD
.: Allergies
.: Alzheimers disease
.: Angina
.: Arthritis
.: Asthma
.: Bacterial infection
.: Birth control
.: Blood disorder
.: Breast cancer
.: Cancer
.: Diabetes
.: Digestive system
.: Ear infections
.: Erectile dysfunction
.: Eye diseases
.: Fever
.: Gastro problems
.: Glaucoma
.: Heart diseases
.: Hormones
.: Infectious diseases
.: Joint pain
.: Kidney stones
.: Lung cancer
.: Lung diseases
.: Mental Health and Depression
.: Mouth diseases
.: Neurological disorder
.: Pain relief
.: Reduce cholesterol
.: Skin diseases
.: Sleep disorder
.: Std
.: Supplement
.: Urinary tract infection
.: Weight loss
.: Womens health

Newsletter

Subscribe to our newsletter:

Name:
E-mail:

Search results

Search results for: formoterol
1 - 2 of 2 <<previous | next>>

Drugs results:

Foradil

Foradil, known also as Formoterol, belongs to the family of medicines known as [beta ]2 -agonists. It is used to help prevent the symptoms of asthma. When used regularly Foradil decreases the number and severity of asthma attacks, but it will not relieve more...

Formoterol

Formoterol is a long-acting bronchodilator that works by relaxing muscles in the airways to improve breathing. Formoterol inhalation is used for the maintenance treatment of bronchial asthma. It is also used to prevent asthma attacks that are brought on more...

Diseases results:

Lung diseases
Asthma

Articles results:

Meeting Highlights From The Committee For Medicinal Products For Human Use, 19-22 March 2007, Europe

Positive opinion for Revlimid The Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Revlimid (lenalidomide), from Celgene Europe, for the treatment of multiple myeloma. EMEA review began on 29 March 2006, with an active review time of 199 days. The active substance of Revlimid, lenalidomide, has a chemical structure that resembles that of thalidomide.

FDA Approves Dey, L.P.'s Perforomist Inhalation Solution For Maintenance Treatment Of COPD

Dey, L.P. has announced that the Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Perforomist™ (formoterol fumarate) Inhalation Solution for long-term, twice-daily maintenance treatment of bronchoconstriction for emphysema and chronic bronchitis, also known as Chronic Obstructive Pulmonary Disease (COPD).Formoterol is a rapid and long-lasting beta2 agonist that has been previously approved in the U.S.

1 - 2 of 2 <<previous | next>>